Zsírmáj (MASLD/MASH): vizsgálatok itt: Oroszország
1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseTaking peopleGepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
- Where
- Tyumen
- Életkor
- 18 év to 65 év
- People
- 90
- Run by
- Phenomen Pharma
See details and how to joinNCT07068191